Biotechnology
Our team regularly advises clients developing biotech products in areas including biotechnology derived proteins (such as insulin), immunologicals (such as vaccines and allergens), blood or plasma derived products, and engineered tissues.
Our team benefits from having several members of the group who have completed degrees in subjects including molecular biology, biochemistry and genetics. This knowledge enables us to quickly grasp technical concepts and provide nuanced and tailored advice.
We closely follow new developments and emerging trends in the biotech market. For example, we have been following the emerging regulatory pathways for biosimilars and advising clients on appropriate strategies.
Explore our sectors
Meet our lawyers
News and insights
News: 09 February 2024
Frankfurt am Main - Allen & Overy a conseillé le groupe Sartorius sur son augmentation de capital d'un montant total de 1,4 milliard d'euros. La transaction comprenait le placement de 613 497 actions…
Publications: 21 July 2023
Le 12 juillet 2023, la Commission européenne (la Commission) a annoncé avoir sanctionné Illumina à hauteur de 432 millions d’euros ainsi que GRAIL, la cible, à une amende symbolique de 1 000 euros…
Publications: 21 July 2022
Le Tribunal de l’UE a rendu un arrêt historique ce 13 juillet 2022 en confirmant la décision de la Commission européenne (la Commission) acceptant une demande de renvoi émanant de la France (et de…